Cannabis Stock Gainers And Losers From November 7, 2019

Gainers

• Cresco Labs CRLBF shares gained 7.22%, closing at $6.50 after launching its community impact incubator program.
• HEXO HEXO shares increased by 2.31% to close at $2.21.
• Harvest Health HRVSF shares increased by 8.5% to close at $2.50.
• Innovative Industrial IIPR shares rallied by 9.96% to close at $79.83, after reporting YoY net income growth of 314%.
• Akerna KERN shares rose 1.69%, to close at $4.22.
• MediPharm Labs MEDIF shares gained 1.69%, closing at $3.90.
• Sundial Growers SNDL shares rose 9.35%, to close at $3.51.
• Supreme Cannabis Co SPRWF shares gained 4.8%, closing at $0.63.
• Therapix Biosciences TRPX shares increased by 1.24% to close at $2.45.
• Valens Groworks VGWCF shares rose 4.41%, to close at $2.37.
• cbdMD YCBD shares gained 4.16%, closing at $4.01.

Losers

Get Started

Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

Get Started

• Aurora Cannabis ACB shares dropped by 4.02%, to close at $3.58.
• Aphria APHA shares tumbled by 2.63%, eventually closing at $4.82.
• Canopy Growth CGC shares tumbled by 1.75%, eventually closing at $19.08.
• Cronos Group CRON shares fell 4.8% to close at $7.93.
• CannTrust Holdings CTST shares dropped by 8.04%, to close at $1.03.
• Fire & Flower Holdings FFLWF shares dropped by 2.86%, to close at $0.73.
• Greenlane Holdings GNLN shares dropped by 9.07%, to close at $3.91.
• GW Pharmaceuticals GWPH shares fell 2.43% to close at $109.04.
• MedMen Enterprises MMNFF shares fell 6.29% to close at $1.08.
• OrganiGram Holdings OGI shares fell 4.86% to close at $3.52.
• Planet 13 Holdings PLNHF shares fell 1.49% to close at $1.32.
• Pyxus International PYX shares tumbled by 11.18%, eventually closing at $9.22.
• Tilray TLRY shares dropped by 2.84%, to close at $22.24.
• Zynerba Pharmaceuticals ZYNE shares tumbled by 4.3%, eventually closing at $6.45.

Related Links:

Tanasi Launches University-Developed, Full-Spectrum Cannabinoid Product Line

USDA's Interim Rules Raise Questions, Possible Jeopardy For Cultivators